Abstract:Phyllanthi Fructus (PF) is a tropical fruit with the potential to effectively reduce postprandial blood glucose, making it highly promising for the development of functional foods. However, the lack of quantitative evaluation methods and comprehensive understanding of active compounds has hindered the development and application of functional foods and dietary supplements derived from PF. In this study, a biological evaluation method of the hypoglycemic activity of PF based on α-glucosidase inhibition was established for the first time. With acarbose as the positive drug and ultrasonic water extract of PF as the test material, the hypoglycemic potency of PF could be accurately evaluated using the "parallel line method of mass reaction". The correlation coefficient (r) between the potency evaluation results and the AUC of postprandial blood glucose concentration in rats was as high as 0.866, confirming a strong correlation between our evaluation results and in vivo effects. The potency of 20 batches of PF samples ranged from 2.66 to 8.39 U·mg-1 with a maximum difference of 3.15-fold. UF-LC-MS was used to identify 36 components of PF capable of binding to α-glucosidase. Molecular docking results showed that the binding energy was between -3.5 and -14.3 kJ/mol. The hypoglycemic activity of 17 available control products was tested and 8 inhibitors were found, including hyperoside, gallic acid and corilagin. Further analysis suggested that flavonoids and polyphenols with a phenolic hydroxyl structure could inhibit α-glucosidase. This study provides valuable information and methodological support for developing PF hypoglycemic functional foods and discovering new active ingredients.

Phloridzin Highly Accumulated in Malus rockii Rehder and Its Structure Revision and Hypolipidemic Activity

Glycyrrhizic Acid-Phospholipid Complex: Preparation Process Optimization and Therapeutic and Pharmacokinetic Evaluation in Rats

Pharmacological activity of phlorizin extracted from leaves of Malus hupehensis

Estrogenic and Antiestrogenic Activities of Phloridzin

Phloroglucinol derivatives with α-glucosidase inhibitory activities from Syzygium fluviatile

Inhibitory Effect of Phloretin on Α-Glucosidase: Kinetics, Interaction Mechanism and Molecular Docking.

alpha-Glucosidase Inhibitory Mechanism of Phloridzin

Hypoglycemic and hypolipidemic activities of phlorizin from <i>Lithocarpus polystachyus</i> Rehd in diabetes rats

Five new phloroglucinol derivatives from Syzygium brachyantherum and their α-glucosidase and PTP1B inhibitory activities

Effects of phloridzin on blood glucose and key enzyme G-6-Pase of gluconeogenesis in mice

Antioxidant Activities of Phloridzin Myristate

Therapeutic indication of Phloridzin: A new Gleam for metabolic disorders

The Bioavailability, Extraction, Biosynthesis and Distribution of Natural Dihydrochalcone: Phloridzin

Inhibition of α-glucosidase activity and intestinal glucose transport to assess in vivo anti-hyperglycemia potential of dodecyl-acylated phlorizin and polydatin derivatives

Phloridzin and the Prevention and Cure of Diabetes Mellitus

Comparative Characterization of the Metabolites of Phloretin and Phlorizin in Rats Using UHPLC-Q-Exactive Orbitrap Mass Spectrometer

Investigation of the hypoglycemic bioactive components of Phyllanthi Fructus through biological assessment combined with ultrafiltration affinity mass spectrometry

Short-term Phlorizin Treatment Attenuates Adipose Tissue Inflammation Without Alerting Obesity in High-Fat Diet Fed Mice

The Molecular Pharmacology of Phloretin: Anti-Inflammatory Mechanisms of Action

Phloridzin Improves Lipoprotein Lipase Activity in Stress-Loaded Miceviaampk Phosphorylation

Genome-wide Identification of Glycosyltransferases Converting Phloretin to Phloridzin in Malus Species.